Clinical Trials Browser

Breast Neoplasms, Male × Everolimus × 90 days × Clear all

NCT01674140 2026-02-10

e3

Phase 3 Active not recruiting

1,939 enrolled 15 charts

Breast Neoplasms, Breast Neoplasms, Male